PMFA
SBBP

Plante Moran Financial Advisors’s Strongbridge Biopharma plc. SBBP Stock Holding History

Plante Moran Financial Advisors’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,500
Closed -$5K – 1037
2020
Q3 		$5K Buy
+2,500
New +$8.43K ﹤0.01% 703

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Plante Moran Financial Advisors's SBBP Position: Q4 2020 in Review

Plante Moran Financial Advisors sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2020, closing a stake of 2,500 shares — an estimated $5K sold.

Plante Moran Financial Advisors first reported a position in SBBP in Q3 2020 and held it in 1 quarter. The position peaked at $5K in Q3 2020. 71 funds tracked by Wall St. Rank hold SBBP as of Q4 2020.

  • Plante Moran Financial Advisors reported no remaining Strongbridge Biopharma plc. position as of Q4 2020 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 2,500 Strongbridge Biopharma plc. shares in Q4 2020, an estimated $5K.
  • Plante Moran Financial Advisors first reported a position in Strongbridge Biopharma plc. in Q3 2020 and held it in 1 quarter.
  • Plante Moran Financial Advisors's Strongbridge Biopharma plc. position peaked at $5K in Q3 2020.
  • 71 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2020.

Based on Plante Moran Financial Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.